Medical Newswire

Medical Newswire!

Medicine, Healthcare, Medical Research, Hospitals, Management
Press release distribution service
Home | Medical-Newswire.Com:

Yasmin Settlements Climb to $142 Million

(EMAILWIRE.COM, May 18, 2012 ) New York, NY – Yasmin settlements have climbed to $142 million, averaging $218,000 per case, according to a number of news sources. Bayer has reportedly resolved 651 lawsuits alleging that its Yasmin and Yaz birth control pills caused sometimes-fatal blood clots in women, with one financial analyst reportedly estimating that Bayer may have to pay out more than $2.65 billion to resolve all cases surrounding these oral contraceptives. If you or a loved one suffered a blood clot while taking Yaz or Yasmin, you may still be able to file a claim against the manufacturer to seek compensation for medical expenses and other losses. To learn more about the Yasmin settlements and to have your claim evaluated at no cost to you, please visit http://www.classaction.org/yaz-yasmin.html today.

The news of the Yasmin settlements came shortly after the FDA ordered a stronger blood clot warning on Yaz and Yasmin labels. The new labels will include information that some studies have found up to a threefold increase in the risk of blood clots with pills containing drospirenone, a hormone found in Yaz, Yasmin and other newer, fourth-generation birth control pills. The agency’s own study found that 10 in 10,000 women taking oral contraceptives containing this synthetic hormone would get a blood clot per year, compared to approximately six in 10,000 women using older birth control pills. This announcement of the label update was made after an advisory committee of outside experts to the agency voted for pills containing drospirenone to undergo a label revision to more clearly outline their risks and benefits.

Reportedly, Bayer is facing 11,900 lawsuits over its Yaz and Yasmin oral contraceptives. Bayer has agreed to settle the first group of lawsuits for venous clot injuries – deep vein thrombosis (DVT) or pulmonary embolism (PE) - while other suits are still in progress. If you suffered a venous clot injury while taking Yaz or Yasmin, it’s not too late to make a claim. For a free evaluation of your blood clot claim, visit ClassAction.org today.

About Class Action.org

Class Action.org is dedicated to protecting consumers and investors in class actions and complex litigation throughout the United States. Class Action.org keeps consumers informed about product alerts, recalls, and emerging litigation and helps them take action against the manufacturers of defective products, drugs, and medical devices. Information about consumer fraud issues and environmental hazards is also available on the site. Visit http://www.classaction.org today for a no cost, no obligation case evaluation and information about your consumer rights.

ClassAction.org
Hannah Armstrong
800-449-1970
pressrelease@lawyercentral.com

Source: EmailWire.com


Medical Resources
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Healthcare resource center today to browse our selection of 600+ complimentary Healthcare magazines, white papers, webinars, podcasts, and more. Get popular titles including:

Eyecare Business
Medical Laboratory Observer
FierceHealthcare

No credit cards, coupons, or promo codes required. Try it today!

Medical Sponsors

Health News
Health News Headlines - Yahoo News
Health News Headlines - Yahoo News
Get the latest health news headlines from Yahoo News. Find breaking health news, including analysis and opinion on top health stories.

FDA approves AbbVie combo hepatitis C treatment
19 Dec 2014 at 12:35pm
WASHINGTON, D.C. (AP) ? Patients with chronic hepatitis C have a new option for treating the liver-damaging virus, with the approval of a combination treatment developed by AbbVie.

U.S. FDA approves AbbVie all-oral hepatitis C treatment
19 Dec 2014 at 12:31pm
(Reuters) - U.S. health regulators on Friday approved AbbVie's all-oral treatment for hepatitis C, providing the first competition for Gilead Sciences huge selling and expensive medicine for the liver-destroying virus. The AbbVie regimen consists of four different anti-viral drugs to be taken as three pills in the morning and one in the evening. The U.S. Food and Drug Administration approved the regimen, which will be sold under the brand name Viekira Pak, for patients with genotype 1 form of the virus, the most common type of hepatitis C and the most difficult to treat. ...


Wall Street adds gains in late trade; energy leads
19 Dec 2014 at 12:31pm

NEW YORK (Reuters) - U.S. stocks gained ground in late afternoon trading on Friday, extending the S&P 500's best two-day run in more than three years, helped by higher energy shares.


Alcohol blackouts common in UK teens
19 Dec 2014 at 12:25pm
By Andrew M. Seaman (Reuters) - About a third of 15-year-olds in the UK have blacked out due to alcohol, a new survey indicates - and the rate rises to nearly three-quarters by the time they reach 19, researchers found. ?Blackout is associated with pretty severe intoxication,? said Dr. Marc Schuckit, the study?s lead author from the University of California, San Diego. It occurs when the blood alcohol level "is about double what is legally drunk.? ?We found that (blackouts) were shockingly common? among the teens in the survey, Schuckit told Reuters Health. ...

Coal ash is not hazardous waste under U.S. agency rules
19 Dec 2014 at 12:23pm
By Jonathan Kaminsky (Reuters) - The U.S. Environmental Protection Agency issued rules on Friday labeling coal ash, a byproduct of coal-based power production containing toxic materials such as arsenic and lead, as non-hazardous waste. The label means that states, and not the EPA, will be the primary enforcers of the new rules, which will require the closure of some coal ash holding ponds leaking contaminants into surrounding water. ...

Coal ash labeled non-hazardous under new U.S. environmental rules
19 Dec 2014 at 11:58am
(Reuters) - The U.S. Environmental Protection Agency issued rules on Friday labeling coal ash, a byproduct of coal-based power production containing toxic materials such as arsenic and lead, as non-hazardous waste. The label means that states, and not the EPA, will be the primary enforcers of new rules, which will require the closure of some coal ash holding ponds leaking contaminants into surrounding water. (Reporting by Jonathan Kaminsky; Editing by Chris Reese)

AstraZeneca cancer drug, companion test approved
19 Dec 2014 at 11:39am
TRENTON, N.J. (AP) ? U.S. regulators on Friday granted accelerated approval to the first in a new class of targeted drugs for ovarian cancer, Lynparza from British drugmaker AstraZeneca PLC.

Obama: U.S. will respond to North Korea-linked hack on Sony
19 Dec 2014 at 11:19am
WASHINGTON (Reuters) - President Barack Obama on Friday said the United States will respond to the devastating cyber attack on Sony Pictures now that U.S. authorities have linked the strike to the North Korean government.

Caramel Apples Linked to 4 Deaths In Multi-State Listeria Outbreak
19 Dec 2014 at 11:07am
Twenty-eight people have become ill in 10 states.

It's time to fight traditions that harm women's health: WHO
19 Dec 2014 at 11:04am
LONDON (Thomson Reuters Foundation) - Some of the major health problems faced by women in developing countries are caused by "terrible" traditions that must be stopped, said the head of public health at the World Health Organisation (WHO). Traditions such as child marriage or female genital mutilation (FGM), widely practised in some communities, contribute to high maternal mortality rates in some poor countries where girls as young as 13 get married and give birth. ...

Prepackaged caramel apples linked to 4 deaths
19 Dec 2014 at 10:58am
WASHINGTON (AP) ? Health officials are warning consumers to avoid prepackaged caramel apples because they are linked to four deaths and more than two dozen illnesses in 10 states.

The Science Behind Nailing Your New Year's Resolution
19 Dec 2014 at 10:44am
Make new year's goals stick past Jan. 2 with these psychological tactics.


AstraZeneca's ovarian cancer drug gets U.S. approval
19 Dec 2014 at 10:38am

(Reuters) - AstraZeneca Plc's ovarian cancer drug has been granted an accelerated approval by the U.S. health regulator, a day after the treatment was approved by the European Commission. An advisory panel to the U.S. Food and Drug Administration had voted in June against granting an accelerated approval to the drug, Lynparza, citing inadequate data. The FDA was earlier scheduled to review the drug on Jan. 3. Lynparza aims to treat ovarian cancer in patients with certain hereditary gene mutations. ...



Taking This Common Pain Reliever Could Add Years To Your Life
19 Dec 2014 at 10:37am

Ibuprofen, a common over-the-counter drug used to relieve pain and fever, could hold the key to a longer, healthier life, according to a study conducted by the Buck Institute for Research on Aging. The study, published in the December edition of PLoS Genetics, found that regular doses of ibuprofen extended the lifespan of yeast, worms and fruit...



UN chief visits Ebola-ravaged West African nations
19 Dec 2014 at 9:56am

MONROVIA, Liberia (AP) ? United Nations Secretary-General Ban Ki-moon praised health workers battling Ebola in Sierra Leone and Liberia on Friday, saying they have shown "the most noble face of humankind" amid an epidemic that has killed more than 6,900 people in West Africa.


Pharmanewswire.com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © GroupWeb Media LLC. All Rights Reserved.

For unlimited press release distribution for $99 per month, call (281) 645-4086 or start posting your press releases online at EmailWire.com. CityRegions.Com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © 2012 GroupWeb Media LLC. All Rights Reserved.


GroupWeb Media Network
AfricaNewswire.Net | AppleNews247.Com | AsiaNewsWire.Net | Aviation-NewsWire | Energy Industry | EstateNewsWire | Entertainment-NewsWire.com | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | EuropeNewsWire.Net | iCameroon.com | i-Canada-News.Com | i-SoftwareNews.com | iT-NewsWire.Com
| InvestorsNewsDesk.Com | i-TravelNewsWire.Com | LegalLaw247.com | Medical-NewsWire.com | MiningNewsWire.net | MoneyNewsWire.Net | Movie-Stars-News.Com | PayDayNews247.Com | PharmaNewsWire.Com | Publishing-NewsWire.Com | Shopping-NewsWire.com | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com |
Medical-Newswire.com - Medicl Newswire and Press Release service of GroupWeb Media LLC